MED insider trading

NYSE Consumer Cyclical

MEDIFAST INC: insider trade history from SEC Form 4 filings.

Total Form 4 trades
532
Last 90 days
10
Buys / sells
17% / 26%
Market cap
$115.30M

About MEDIFAST INC

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans consisting of 5 & 1 Plan and 5 & 1 ACTIVE Plan, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss without the stress of figuring out what to eat. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.

Company website: medifastinc.com

MED insider activity at a glance

FilingIQ tracks 532 insider transactions for MED in filings since Jan 5, 2015. The most recent transaction is dated Sep 29, 2026.

Across the full history, 89 open-market purchases and 140 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MED insider trades is 47.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest MED Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Consumer Cyclical tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for MED?
FilingIQ tracks 532 Form 4 insider transactions for MED (MEDIFAST INC), covering filings from Jan 5, 2015 onwards. 10 of those are dated within the last 90 days.
Are MED insiders net buyers or net sellers?
Across the full Form 4 history for MED, 89 transactions (17%) were open-market purchases and 140 (26%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MED insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is MED in?
MEDIFAST INC (MED) is classified in the Consumer Cyclical sector, specifically Personal Services, with a current market capitalisation of $115.30M.

Methodology & sources

Every MED insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.